跳到正文

疾病

肺癌Lung cancer

肺癌 · ICD-10:C34 — Malignant neoplasm of bronchus and lung

疾病详情

规范中文名
肺癌
英文名
Malignant neoplasm of bronchus and lung

以中文写出的数值按来源原样引用。

又称

  • 支气管肺癌
  • 非小细胞肺癌(NSCLC)
  • 小细胞肺癌(SCLC)
  • Lung cancer
  • LC
  • NSCLC
  • SCLC

治疗费用区间

以下每个区间都按一种计费口径发布:医保报销前。 来源未发布报销后数值,因此这里不展示。

治疗路径 费用区间 价格依据 数据年份
手术 52000 – 81790 CNY 病种打包全包价 2020–2025
放疗 19000 – 58000 CNY 项目价 2025–2026
化疗 6550 – 9500 CNY 病种打包全包价 2020–2021
靶向 20000 – 60000 CNY 项目价 2024–2025
免疫 32043 – 43803 CNY 项目价 2024–2025

上方的条形共用同一刻度:每条从该行已发布的下限值起,到其上限值止。本页最高的上限值为 81790 CNY。每行保留自己的数据年份与口径。

该疾病的 5 个费用区间,来源见各行页面。

以中文写出的数值按来源原样引用。

查看全部费用区间 →

五年生存

5 年生存率 28.7% 95% 置信区间 28.6–28.9

人群
总体(全分期合并)· 年龄标准化相对生存率
时期
2019–2021
发布机构
国家癌症中心
数值性质
估计值(混合法)
登记范围
281 个肿瘤登记处
分期数据可用性
未按分期发布(来源仅发布总体数值)

以中文写出的数值按来源原样引用。

查看全部生存率 →

如何解读该数据。 它按全分期合并发布,因此是全国登记数据中所有人的平均值,而不是对某个人的预后。对多数癌症而言,确诊时的分期是生存差异背后最强的单一因素:通常,癌症发现得越早,生存率越高;发现得越晚,越低。不同癌症之间的比较也受到各自通常确诊早晚的影响,因此一个较低的数值本身并不意味着诊疗更差。

该数值是相对生存率:它把被诊断患此癌的人与一般人群中同年龄、同性别的人相比较,且为年龄标准化,因此它不是五年后仍存活患者所占的比例。它以估计值(混合分析)发布,因为登记报告存在滞后,故国家癌症中心对最近一段时期作了模型估计。作为参照,同一来源发布 2019–2021 年全部癌症合计的五年相对生存率为 43.7%。

在该疾病上有已发布记录的医院

依据官方公开数据来源筛选

这些医院依据官方公开数据来源筛选——复旦大学医院专科声誉排行榜、国家临床重点专科名单与国家临床医学研究中心——因此卡片上的每一行都可与其已发布的来源核对。这不是付费或推广位。

这些医院是如何筛选的

入选。当某疾病所归属的专科满足以下至少一项时,医院即被列入该疾病:在复旦大学医院专科声誉排行榜中有一个名次或提名;有一条 A、B 或 C 级的国家临床重点专科记录;或该专科有一个国家临床医学研究中心或国家重点实验室。JCI 认证仅作徽标展示;它绝不决定入选,也绝不决定排序。

排序。第 1 步:该专科在复旦榜中的第 1 至第 10 名。第 2 步:又一个复旦名次,或一个提名。第 3 步:一条 A 级国家临床重点专科。第 4 步:一条 B 级国家临床重点专科。第 5 步:该专科的一个国家临床医学研究中心或国家重点实验室,研究中心优先于实验室。第 6 步:一条 C 级国家临床重点专科——这是我们发布的一条没有独立官方来源的记录,因此排在其余之后。

平局。在同一步骤内:复旦名次更好的在前,其次重点专科等级更高者(A 先于 B,B 先于 C),再次省份,再次城市,最后医院名称——与医院目录所用的省—市—名称顺序相同。最多列出八家医院。

当名单较短时。五家及以上:列出前八家。三家或四家:全部列出,并有一个可展开的折叠区,把其余记录补至最多八条,每条都带其证据等级。一两家:同上,且该折叠区默认展开,并有一行说明有多少家医院有可靠的公开记录。没有:页面说明未找到可靠的公开记录,并链接到专科目录。绝不为了凑数而编造名次、机构或数量。

复旦排行榜是中国临床医生最广泛认可的医院专科声誉排行榜,由复旦大学医院管理研究所每年发布。

  1. 广州医科大学附属第一医院First Affiliated Hospital of Guangzhou Medical University

    Guangzhou 广州市

    复旦专科声誉排行榜 2023

    国家临床重点专科

    研究平台

    同时上榜:在复旦榜中为 Urology 获提名。

  2. 中国医学科学院肿瘤医院Cancer Hospital of Chinese Academy of Medical Sciences

    Beijing 北京市

    复旦专科声誉排行榜 2023

    国家临床重点专科

    同时上榜:在复旦榜中为 Medical Oncology #1, Urology 获提名。

  3. 上海市胸科医院(暨上海交通大学医学院附属胸科医院)Shanghai Chest Hospital

    Shanghai 上海市

    复旦专科声誉排行榜 2023

    国家临床重点专科

    已发表研究

    另有 3 项已发表研究

    PubMed 收录了 5 篇关于该疾病、并提及这家医院的论文。

  4. 中日友好医院China-Japan Friendship Hospital

    Beijing 北京市

    复旦专科声誉排行榜 2023

    已发表研究

    另有 2 项已发表研究

    PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

  5. 四川大学华西医院West China Hospital, Sichuan University

    Chengdu 成都市

    复旦专科声誉排行榜 2023

    国家临床重点专科

    同时上榜:在复旦榜中为 General Surgery #3, Urology #2 (并列), Otorhinolaryngology #8。

  6. 上海市肺科医院Shanghai Pulmonary Hospital

    Shanghai 上海市

    复旦专科声誉排行榜 2023

  7. 中国医学科学院北京协和医院Peking Union Medical College Hospital

    Dongcheng District 东城区

    复旦专科声誉排行榜 2023

    同时上榜:在复旦榜中为 General Surgery #1, Urology #8, Gynecology #1。

  8. 上海交通大学医学院附属瑞金医院Ruijin Hospital

    Shanghai 上海市

    复旦专科声誉排行榜 2023

    国家临床重点专科

    已发表研究

    PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

    同时上榜:在复旦榜中为 General Surgery #4, 传染感染 #6, 核医学 #10。

临床试验(在研治疗)

除标准治疗外,针对 Lung cancer 的临床研究目前可能在中国开放招募受试者。在研治疗尚未获监管机构批准为标准疗法——它们是临床研究,而非常规治疗。每条记录都注明主要研究者与开展研究的医院。如有兴趣,请联系医院了解是否符合条件,并自行决定是否申请。

  1. 研究 A Randomized, Double-Blind, Placebo-Controlled, Multi-Regional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy

    医院
    Third Affiliated Hospital of Harbin Medical University
    状态
    招募中
    登记库
    NCT06095583
  2. 研究 A Phase 1/2 Adaptive Dose-Escalation and Expansion Study of Dual-Targeting Chimeric Antigen Receptor Natural Killer (CAR-NK) Cells Directed Against DLL3, CD56 (NCAM1), and/or GD2 in Adults With Relapsed/Refractory Small Cell Lung Cancer

    医院
    Peking University Shenzhen Hospital
    状态
    招募中
    登记库
    NCT07480213
  3. 研究 A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

    主要研究者
    Qiming Wang · Director
    医院
    Henan Cancer Hospital
    状态
    招募中
    登记库
    NCT07559786
  4. 研究 Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy: a Multicenter Randomized Controlled Phase III Clinical Trial

    主要研究者
    Jinming Yu · Director of Shandong Cancer Hospital and Institute
    医院
    Shandong Cancer Hospital
    状态
    招募中
    登记库
    NCT04829708
  5. 研究 Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer

    主要研究者
    Wei Zhang · Chief Physician
    医院
    Shanghai Chest Hospital
    状态
    招募中
    登记库
    NCT07070011
另有 136 项已登记研究
  1. 研究 A Phase II, Single-Arm, Prospective Study of Neoadjuvant Icotinib With Chemotherapy for the Treatment of Patients With Epidermal Growth Factor Receptor Mutation Positive, Resectable for Stage II to IIIB(N2) Non-small Cell Lung Cancer

    主要研究者
    Wu Nan · Principal Investigator
    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT05104788
  2. 研究 A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07413042
  3. 研究 Neoadjuvant Sintilimab or Combined With Chemotherapy for Stage III Driven Gene Mutation Negative Non-small Cell Lung Cancer

    主要研究者
    Peng Zhang · Director of thoracic department
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT04728724
  4. 研究 Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression

    主要研究者
    Chunxia Su · Director of the Clinical Research Center
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT06749860
  5. 研究 Evaluation of AI-Assisted Versus Conventional Human Reading for Lung Cancer Screening in Community-Based Settings: A Randomized Controlled Trial

    主要研究者
    Jianxing He · Professor
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06988579
  6. 研究 Construction and Evaluation of a Hospital-Community Health Collaboration Model Empowered by Digital Technology for Lung Cancer Screening

    主要研究者
    Jianxing He · Director
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06988943
  7. 研究 Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics to Explore Biomarkers and Therapeutic Mechanisms.

    主要研究者
    Jianxing He · Professor
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06843707
  8. 研究 Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial

    主要研究者
    Chang Chen
    状态
    招募中
    登记库
    NCT05053802
  9. 研究 A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic Non-small Cell Lung Cancer

    医院
    The First Affiliated Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT07227025
  10. 研究 A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Anti-Tumor Efficacy and Safety of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery (WU-KONG16)

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07182682
  11. 研究 Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable for Surgical Resection

    医院
    The Second Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06492421
  12. 研究 A Phase III, Multicenter, Randomized, Controlled, Open-label Clinical Study to Evaluate the Efficacy and Safety of YL201 in Combination With Serplulimab Versus Carboplatin and Etoposide in Combination With Serplulimab as First-line Treatment in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer

    医院
    Sun Yat-sen University Cancer Center
    状态
    招募中
    登记库
    NCT07739758
  13. 研究 Efficacy and Safety of Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy as Neoadjuvant Treatment for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer: A Multicenter, Single-Arm, Prospective Phase II Clinical Trial

    主要研究者
    Hu Liao · Deputy Director & Medical Team Leader, Department of Thoracic Surgery, West China Hospital, Sichuan University; Associate Professor of Surgery; Master's Supervisor
    医院
    The Third People's Hospital of Chengdu
    状态
    招募中
    登记库
    NCT07855965
  14. 研究 A Phase 1/2 Adaptive Dose-Escalation and Expansion Study of Dual-Targeting Chimeric Antigen Receptor Natural Killer (CAR-NK) Cells Directed Against DLL3, CD56 (NCAM1), and/or GD2 in Adults With Relapsed/Refractory Small Cell Lung Cancer

    医院
    Peking University Shenzhen Hospital
    状态
    招募中
    登记库
    NCT07744256
  15. 研究 A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Patients With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06793215
  16. 研究 A Prospective, Single Arm, Phase II Clinical Study of Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer

    主要研究者
    Wei Zhou · Department Director
    医院
    Chongqing University Cancer Hospital
    状态
    招募中
    登记库
    NCT07425795
  17. 研究 Immunonutrition in Reducing Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer: a Prospective, Randomized, Controlled, Open-label Clinical Trial

    主要研究者
    HuaiLiu · Prof.
    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT06840704
  18. 研究 A Phase Ib/III Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Immunogenicity of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

    医院
    Tianjin Medical University Cancer Institute & Hospital
    状态
    招募中
    登记库
    NCT06417008
  19. 研究 A Multicenter, Open-label, Dose-Escalation and Dose-Expansion Phase I/II Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

    医院
    Shanghai Chest Hospital
    状态
    招募中
    登记库
    NCT06903377
  20. 研究 A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy:A Phase II Trial

    主要研究者
    Xuwei Cai · Director
    医院
    Shanghai Chest Hospital
    状态
    招募中
    登记库
    NCT07091305
  21. 研究 A Multicenter, Randomized, Controlled, Open-label, Phase IIa Trial on Autologous Tumor Infiltrating Lymphocyte Injection (LM103 TILs) for the Adjuvant Treatment of Non-small Cell Lung Cancer With Negative Driver Gene Mutations

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT07444437
  22. 研究 Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Single-arm, Phase 2 Trial

    主要研究者
    Peng Zhang · Director
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT06256237
  23. 研究 Exploration on the Value of Molecular Residual Disease Based on Circulating Tumor DNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

    主要研究者
    Peng Zhang · Professor
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT05965024
  24. 研究 Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer: a Prospective, Observational Study

    主要研究者
    Chang Chen · Deputy Director of MD. PhD. Program in Thoracic Surgery, Secretary of the party committee of Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT07328945
  25. 研究 Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy Study of the Combination Therapy With HC010 for Injection in Patients With Advanced Solid Tumors:A Multicenter, Open-Label, Dose Range-Finding and Multiple Cohort Dose Expansion Phase Ib Clinical Trial-Lung Cancer Population

    医院
    Sun Yat-sen University Cancer Center
    状态
    招募中
    登记库
    NCT07381829
  26. 研究 A Prospective, Single-arm, Multicenter, Phase II Clinical Study on Envafolimab Combined With Disitamab Vedotin And Carboplatin for Resectable, Stage II-III, HER2-Mutant Non-Small Cell Lung Cancer

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT06734182
  27. 研究 A Multicenter Phase II/III Study Evaluating the Efficacy and Safety of SCTB41 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Driver-Negative Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT07662395
  28. 研究 A Randomized, Open Label, Multicenter, Phase 3 Trial Evaluating the Efficacy and Safety of TAK-928 Versus Docetaxel in Participants With Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Disease Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT07217301
  29. 研究 An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Efficacy, and Pharmacokinetics in Participants With Small Cell Lung Cancer

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT06179069
  30. 研究 Comparison of Segmentectomy Versus Lobectomy for Early-stage Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field: A Prospective and Multi-center RCT Study

    医院
    Jiangsu Province Hospital
    状态
    招募中
    登记库
    NCT04944563
  31. 研究 PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

    医院
    Anhui Provincial Hospital
    状态
    招募中
    登记库
    NCT07144280
  32. 研究 DAREON ® -Lung-1: A Phase III Multi-center, Open-label, Randomised Trial of Intravenous Obrixtamig in Combination With Atezolizumab, Carboplatin, and Etoposide vs. Atezolizumab, Carboplatin, and Etoposide as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07472517
  33. 研究 A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06801834
  34. 研究 A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202)

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT05920356
  35. 研究 Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients: a Triple Blinded, Randomized Controlled Trial to Assess the Efficacy of Tranexamic Acid for Hemostasis

    医院
    The Second Affiliated Hospital Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT06023212
  36. 研究 A Phase I/II Multicenter, Open Label, Single-arm Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of WSD0922-FU in the Treatment of Advanced Non-small Cell Lung Cancer

    医院
    Anhui Provincial Hospital
    状态
    招募中
    登记库
    NCT06631989
  37. 研究 Targeting Delta-like Ligand 3 (DLL3) With 68Ga-PFD3 PET/CT for the Diagnosis and Assessment of Small Cell Lung Cancer (SCLC)

    主要研究者
    Tingting Yuan · Attending physician
    医院
    Peking University First Hospital
    状态
    招募中
    登记库
    NCT07508852
  38. 研究 Effectiveness of Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer:A Randomized Controlled Clinical Study

    主要研究者
    Liu Zhishun · professer,Chief Physician
    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT06926140
  39. 研究 TCR-T Cells Targeting Cancer Cells for Immunotherapy of Lung Cancer and Other Solid Tumors: Phase I Clinical Trial

    医院
    The Second Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT03778814
  40. 研究 Observational Study on the Efficacy and Safety of Huaier Granules Compared With Platinum Containing Dual Drug Combination Chemotherapy in Adjuvant Therapy for Resectable Stage II-IIIA Non-small Cell Lung Cancer After Radical Surgery

    主要研究者
    Hongxu Liu · professor
    医院
    Liaoning Cancer Hospital
    状态
    招募中
    登记库
    NCT06109454
  41. 研究 Prospective, Single-arm Phase II Clinical Study of Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

    主要研究者
    HAN GUANG · Chief physician
    医院
    Hubei Cancer Hospital
    状态
    招募中
    登记库
    NCT06032052
  42. 研究 ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07361497
  43. 研究 A Single Arm, Open Label, Dose-escalating, Prospective Phase I Clinical Trial Evaluating the Safety, Tolerability and Efficacy of TMT101 Injection Alone in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC) After Standard Treatment Failure

    主要研究者
    Wu Wenming · Director, Chief Physician of Basic Surgery, Principal Investigator, Clinical Professor
    医院
    Peking Union Medical College Hospital
    状态
    招募中
    登记库
    NCT06861543
  44. 研究 A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT07143045
  45. 研究 Low-dose Radiation Therapy and Stereotactic Body Radiation Therapy Combined With PD-1 Inhibitor Sintilimab and Chemotherapy Versus PD-1 Inhibitor Combined With Chemotherapy as First-line Treatment for Patients With Locally Advanced or Metastatic Squamous Cell Lung Cancer: A Randomized, Phase II Multicenter Clinical Trial

    主要研究者
    You Lu · Chair of Division of Thoracic Tumor Multimodality Treatment
    医院
    The Second Affiliated Hospital of Chongqing Medical University
    状态
    招募中
    登记库
    NCT06121505
  46. 研究 Delta-like Protein 3 (DLL3)- Targeted PET Imaging in Small Cell Lung Cancer

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07677787
  47. 研究 Randomized, Double-Blind, Multicenter Phase III Study of RC148 in Combination With Platinum-Based Chemotherapy Versus Tislelizumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT07416474
  48. 研究 A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre Study of Almonertinib as Maintenance Therapy in Patients With Locally Advanced, Unresectable EGFR Mutation-positive Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based Chemoradiation Therapy

    医院
    Shandong Cancer Hospital
    状态
    招募中
    登记库
    NCT04951635
  49. 研究 The Therapeutic Effect of Irinotecan Liposomes Combined With Cisplatin/Carboplatin for Platinum Sensitive Recurrent Small Cell Lung Cancer

    状态
    招募中
    登记库
    NCT06467786
  50. 研究 A Phase II Clinical Study to Evaluate the Efficacy and Safety of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07622186
  51. 研究 Efficacy and Safety of PD-L1 Inhibitor Rechallenge After Immune Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer: A Multicenter Real-World Study

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07775820
  52. 研究 Tubeless Anesthesia in Preventing Contralateral Lung Complications in Patients Undergoing Single-Port Thoracoscopic Surgery for Early-Stage Lung Cancer: A Single-Center, Prospective, Open-Label, Randomized Controlled Trial

    医院
    Fujian Medical University Union Hospital
    状态
    招募中
    登记库
    NCT07024433
  53. 研究 Effectiveness of Perioperative Percutaneous Acupoint Acupuncture on Postoperative Sleep Disturbances in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial

    主要研究者
    LIna Huang · Chief Physician, Department of Anesthesiology, Shanghai First People's Hospital
    医院
    Shanghai General Hospital
    状态
    招募中
    登记库
    NCT07662733
  54. 研究 Electroacupuncture Combined With 5-HT3 Receptor Inhibitor for the Prevention of Postoperative Nausea and Vomiting in High-risk Patients Undergoing Thoracoscopic Surgery for Lung Cancer

    主要研究者
    Cai Xiaoyue · Associate Chief Physician
    医院
    Shanghai Chest Hospital
    状态
    招募中
    登记库
    NCT07515027
  55. 研究 Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients With Chinese Advanced Non-small Cell Lung Cancer

    主要研究者
    Xiaomin Niu · Principal Investigator
    医院
    Shanghai Chest Hospital
    状态
    招募中
    登记库
    NCT04977791
  56. 研究 Randomized Controlled Study on Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform

    主要研究者
    Xinghua Cheng · Director, Head of Oncology Surgery, Clinical Professor
    医院
    Shanghai Chest Hospital
    状态
    招募中
    登记库
    NCT06483295
  57. 研究 The Efficacy and Safety of the Combination of Sintilimab With Platinum-doublet Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients

    主要研究者
    Xuewen Liu · Professor
    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT07138755
  58. 研究 A Phase I Clinical Study to Explore the Safety and Efficacy of Hypervision Proton Surgery (HyPROS) for Early-stage Non-small Cell Lung Cancer

    主要研究者
    Shuanghu Yuan · Professor
    医院
    Anhui Provincial Hospital
    状态
    招募中
    登记库
    NCT07195084
  59. 研究 A Multicenter, Randomized, Double-blind, Phase III Clinical Study of Comparing the Efficacy and Safety of AK112 (PD-1/VEGF Bispecific Antibody) Versus Placebo as Consolidation Treatment for Patients With Limited Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07010263
  60. 研究 Prospective Cohort Study on Risk Factors and Machine Learning-Based Prediction of Postoperative Venous Thromboembolism in Patients Undergoing Lung Cancer Surgery

    医院
    The First Hospital of Jilin University
    状态
    招募中
    登记库
    NCT07439991
  61. 研究 An Open Label, First-in-human Study of BAY 2927088 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring an EGFR and/or HER2 Mutation

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT05099172
  62. 研究 Exploratory Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer(ES-SCLC).

    主要研究者
    Rong Yu, MD · Investigator Official Title
    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06768307
  63. 研究 A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06312137
  64. 研究 Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) for CEA Positive Advanced Lung Cancer

    状态
    招募中
    登记库
    NCT06992583
  65. 研究 Surgery or Radiotherapy After PD-L1 Inhibitor (TQB-2450) and Chemotherapy Induction Therapy in Patients With Limited-stage Small-cell Lung Cancer

    主要研究者
    Peng Zhang · Director of science and education department
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT04539977
  66. 研究 Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment (NAT-LungMate)

    主要研究者
    Peng Zhang · Professor
    医院
    Shanghai Pulmonary Hospital
    状态
    招募中
    登记库
    NCT05857800
  67. 研究 Multicenter, Retrospective, Observational Study of Icotinib for Post-Surgical Adjuvant Therapy in Stage IA2 High-Risk to IB Non-Small-Cell Lung Cancer With Positive EGFR-Sensitive Mutations

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT07806604
  68. 研究 The Shengjing Lung Cancer Cohort (SJ-LCC) Study

    主要研究者
    Huanhuan Chen · Shengjing Hospital of China Medical University
    医院
    Shengjing Hospital
    状态
    招募中
    登记库
    NCT07779005
  69. 研究 A Phase II Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade (PD-1/CTLA-4) in Patients With Locally Advanced Non-Small Cell Lung Cancer

    主要研究者
    Hui Liu · Professor
    医院
    Sun Yat-sen University Cancer Center
    状态
    招募中
    登记库
    NCT07103395
  70. 研究 LcProt: Proteomics Longitudinal Cohort Study on Lung CancerProspective Longitudinal Cohort Study of Lung Cancer Based on Peripheral Blood and Tissue Proteomics

    主要研究者
    Jianxing He · Professor
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT06778512
  71. 研究 An Apen-label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of BEBT-109 in Patients With EGFR Exon 20 Insertion Mutations in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT06706713
  72. 研究 Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients(PRE-EXELUCA): a Prospective Randomized Controlled Clinical Trial

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT06215326
  73. 研究 Beamion 44: A Randomized, Open-label, Multi-center Phase IIa Platform Trial to Evaluate the Safety and Tolerability of Zongertinib Plus Platinum-based Doublet Chemotherapy With or Without Pembrolizumab (and Potential Other Combinations) in Treatment-naïve Patients With Locally Advanced/Metastatic Non-squamous NSCLC With Activating HER2 Mutations

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT07486817
  74. 研究 A Prospective, Multicenter, Randomized Controlled, Phase II Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

    主要研究者
    Xingwen Fan · associate professor
    医院
    Fudan University Shanghai Cancer Center
    状态
    招募中
    登记库
    NCT06943235
  75. 研究 Mechanisms of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

    主要研究者
    Yang Fan, MD · Vice President
    医院
    Peking University People's Hospital
    状态
    招募中
    登记库
    NCT07359040
  76. 研究 A Phase II/III Clinical Study on the Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Perioperative Treatment of Resectable Stage II/III Non Small Cell Lung Cancer.

    医院
    Cancer Hospital of Chinese Academy of Medical Sciences
    状态
    招募中
    登记库
    NCT05913089
  77. 研究 A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)

    医院
    China-Japan Friendship Hospital
    状态
    招募中
    登记库
    NCT06203210
  78. 研究 Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

    医院
    First Affiliated Hospital of Zhengzhou University
    状态
    招募中
    登记库
    NCT06950697
  79. 研究 Exploration of and Model Establishment of the Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy

    主要研究者
    Guangying Zhu · Clinical Professor, Chief Physician
    医院
    China-Japan Friendship Hospital
    状态
    招募中
    登记库
    NCT06692972
  80. 研究 A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV 324 in Adults With Hepatocellular Cancer or Squamous Cell Non-Small Cell Lung Cancer

    医院
    Nanfang Hospital
    状态
    招募中
    登记库
    NCT06858813
  81. 研究 Cohort Studies of Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer, Including Non-small-cell Lung Cancer and Small-cell Lung Cancer With Early and Advanced Staging (STRESS-LUNG)

    主要研究者
    Fang Wu · Professor
    医院
    Xiangya Hospital of Central South University
    状态
    招募中
    登记库
    NCT05477979
  82. 研究 Study of Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer (BRIO)

    主要研究者
    Fang Wu · Chief Physician, Associate Professor
    医院
    Second Xiangya Hospital of Central South University
    状态
    招募中
    登记库
    NCT05979818
  83. 研究 The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer, Including Non-small-cell Lung Cancer and Small-cell Lung Cancer With Early and Advanced Staging

    主要研究者
    Fang Wu · Professor
    医院
    Xiangya Hospital of Central South University
    状态
    招募中
    登记库
    NCT06975384
  84. 研究 Comprehensive Multi-Omics Analysis of Early-Stage Lung Cancer Exhibiting Distinct Phenotypes

    主要研究者
    Chen Chen · Associate Professor
    医院
    Second Xiangya Hospital of Central South University
    状态
    招募中
    登记库
    NCT06699979
  85. 研究 A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression

    医院
    Guangdong Provincial People's Hospital
    状态
    招募中
    登记库
    NCT07412262
  86. 研究 A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06899126
  87. 研究 Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    招募中
    登记库
    NCT07059923
  88. 研究 Assessment the Association of Imaging and Tumor Microenvironment in Lung Cancer With Radiogenomics

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    招募中
    登记库
    NCT06500312
  89. 研究 A Phase II Clinical Study to Evaluate the Efficacy and Safety of SI-B003 Monotherapy and BL-B01D1+SI-B003 Combination Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

    医院
    Chongqing University Cancer Hospital
    状态
    招募中
    登记库
    NCT05956587
  90. 研究 The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer: a Prospective, Observationa Trial

    医院
    Ruijin Hospital
    状态
    招募中
    登记库
    NCT06623487
  91. 研究 A Phase 3 Multicenter Open-label Study of Taletrectinib Versus a Standard of Care ROS1-Tyrosine Kinase Inhibitor (Crizotinib) in TKI-Naïve Patients With ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRUST-III)

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    招募中
    登记库
    NCT06564324
  92. 研究 Impact of Intraoperative Blood Pressure Management and Dexamethasone on Patient's Outcomes After Lung Cancer Surgery: A 2 × 2 Factorial Randomized Controlled Trial

    主要研究者
    Dong-Xin Wang · Chairman, Department of Anaesthesiology and Critical Care Medicine
    医院
    Peking University First Hospital
    状态
    招募中
    登记库
    NCT04209218
  93. 研究 Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)

    医院
    The First Affiliated Hospital of Nanchang University
    状态
    尚未招募
    登记库
    NCT04846634
  94. 研究 A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy

    主要研究者
    Ren Shengxiang · professor
    医院
    Jiangsu Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07101627
  95. 研究 INFORM: A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy

    主要研究者
    Jianxing He · Professor
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT06422637
  96. 研究 Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemotherapy Combined With Immunotherapy for the Treatment of Clinical Stage IIA-IIIB (N2) Non-small Cell Lung Cancer

    主要研究者
    Wen-zhao ZHONG · Head of Thoracic Surgery
    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT07617389
  97. 研究 Iparomlimab and Tuvonralimab (QL1706) Combined Chemotherapy and Quad Shot Radiotherapy in First-line Treatment of Driver Gene-negative Advanced Non-small Cell Lung Cancer: a Randomized, Controlled, Phase 2, Open-label Trial.

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    尚未招募
    登记库
    NCT07271602
  98. 研究 An Open, Multi-center Phase I Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

    医院
    Third Affiliated Hospital of Harbin Medical University
    状态
    尚未招募
    登记库
    NCT07550842
  99. 研究 A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

    医院
    First Affiliated Hospital of Xiamen University
    状态
    尚未招募
    登记库
    NCT07031154
  100. 研究 Exploratory Clinical Study on Microwave Ablation With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer

    主要研究者
    Jiayuan Sun · Chief Physician
    医院
    Shanghai Chest Hospital
    状态
    尚未招募
    登记库
    NCT06969781
  101. 研究 Efficacy and Safety of Septum-guided Segmentectomy for 2-3 cm Clinical Stage IA3 Peripheral Non-Small Cell Lung Cancer: A Single-Center, Prospective, Single-Arm Clinical Trial

    主要研究者
    Junfeng Geng · Professor
    医院
    Shanghai Chest Hospital
    状态
    尚未招募
    登记库
    NCT07780591
  102. 研究 An Open-label, Single-center, Phase II Study of Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung Cancer

    医院
    The First Hospital of Jilin University
    状态
    尚未招募
    登记库
    NCT05784974
  103. 研究 Postoperative Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD: a Single-arm, Multicenter Study

    主要研究者
    Wu Nan · Professor
    医院
    Peking University Cancer Hospital
    状态
    尚未招募
    登记库
    NCT06780839
  104. 研究 Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial

    主要研究者
    Chang Chen · Deputy Director of MD. PhD. Program in Thoracic Surgery, Secretary of the party committee of Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
    医院
    Shanghai Pulmonary Hospital
    状态
    尚未招募
    登记库
    NCT06620822
  105. 研究 A Multicenter Randomized Controlled Trial of an Intelligent Pulmonary Function Exercise Device Versus Usual Care for In-Hospital and Home-Based Pulmonary Rehabilitation After Lung Cancer Surgery

    主要研究者
    Jianxing He · Principal Investigator
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT07631520
  106. 研究 A Randomized Controlled Trial Evaluating the Effectiveness of a Novel Risk-Stratified Screening Strategy for Lung Cancer

    主要研究者
    Jianxing He · Principal Investigator
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT07078032
  107. 研究 A Clinical Study Evaluating the Safety and Efficacy of Golidocitinib in Patients With Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer

    主要研究者
    Jianxing He · Director, Head of Thoracic Surgery, Principal Investigator, Clinical Professor
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT07303881
  108. 研究 Predictive Value of CEA and ctDNA for Postoperative Recurrence in Patients With High CEA Sensitivity Lung Cancer

    医院
    Guangdong Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT07170046
  109. 研究 Development of a Chest CT-Based Artificial Intelligence Model Across the Lung Cancer Care Continuum and a Prospective Randomized Crossover Reader Study of Its Clinical Decision-Support Performance

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    尚未招募
    登记库
    NCT07829640
  110. 研究 A Phase II/III Clinical Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)

    医院
    Sun Yat-sen University Cancer Center
    状态
    尚未招募
    登记库
    NCT07739199
  111. 研究 The Effects of Acupuncture for Lung Cancer-Related Fatigue, a Clinical Trial

    主要研究者
    Yuanjie Sun · Doctor
    医院
    Guang'anmen Hospital of China Academy of Chinese Medical Sciences
    状态
    尚未招募
    登记库
    NCT07079072
  112. 研究 Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer (PRIORITY): a Prospective Single Center, Open Label, Phase II Study

    医院
    Ningbo No.2 Hospital
    状态
    尚未招募
    登记库
    NCT06221462
  113. 研究 A Randomized, Double-blind, Phase III Trial to Compare the Efficacy and Safety of AK104 Combined With Chemotherapy to Tislelizumab Combined With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer (NSCLC)

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT05990127
  114. 研究 Randomized Clinical Trials Comparing Immunotherapy Plus Cryoablation (I-CA) Versus Cryoablation Alone for Stage I, Selected Stage IIa, Non-Small Cell Lung Cancer

    主要研究者
    Jiayuan Sun · Director, Department of Respiratory Endoscopy
    医院
    Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
    状态
    尚未招募
    登记库
    NCT06580665
  115. 研究 Organoid-Based Drug Sensitivity Model Guided Personalized Precision Treatment for Extensive-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Randomized Controlled Trial

    医院
    Peking Union Medical College Hospital
    状态
    尚未招募
    登记库
    NCT07106528
  116. 研究 A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT05767892
  117. 研究 Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

    医院
    Henan Cancer Hospital
    状态
    尚未招募
    登记库
    NCT06236997
  118. 研究 An Investigator-initiated Trial Evaluating the Efficacy and Safety of Anti-Trop2 Universal CAR-NK(U-CAR-NK) Cells Therapy Combined With Chemotherapy for Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

    主要研究者
    Qiming Wang · Professor
    医院
    Henan Cancer Hospital
    状态
    尚未招募
    登记库
    NCT06454890
  119. 研究 Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

    主要研究者
    Liu Fang · Director
    医院
    Third Affiliated Hospital of Harbin Medical University
    状态
    尚未招募
    登记库
    NCT07398560
  120. 研究 Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial

    主要研究者
    Zhang Zhi · Associate Professor
    医院
    Jiangsu Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07286942
  121. 研究 Efficacy and Safety of Induction Chemoimmunotherapy Followed by Carbon Ion Radiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

    主要研究者
    Ji Yongling · PI
    医院
    Zhejiang Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07035860
  122. 研究 A Prospective, Multicenter, Randomized Controlled Clinical Trial Comparing Bronchoscopic Thermal Vapor Ablation and Percutaneous Microwave Ablation in Patients With COPD and Early-Stage Lung Cancer: Efficacy and Safety Evaluation

    医院
    Henan Provincial People's Hospital
    状态
    尚未招募
    登记库
    NCT06929390
  123. 研究 Effects of Different Preoperative Oral Rehydration Protocols on Safety, Comfort, and Postoperative Outcomes in Elderly Patients Undergoing Thoracoscopic Radical Lung Cancer Surgery: A Randomized Controlled Trial

    医院
    Fujian Medical University Union Hospital
    状态
    尚未招募
    登记库
    NCT07042503
  124. 研究 The Impact of SGLT2i on the Outcome of Advanced Lung Cancer in Patients With Diabetes

    主要研究者
    Liang Zhao · Dr
    医院
    Shanghai Chest Hospital
    状态
    尚未招募
    登记库
    NCT07272057
  125. 研究 Phase I Study of Anti-EGFR/c-Met Bispecific Antibody MCLA-129 Combined With Befotertinib in Patients of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation To Evaluate The Safety, Pharmacokinetic Characteristics and Antitumor Activity

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT06015568
  126. 研究 A Single-Arm Phase II Study of Intrathecal Thiotepa Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI

    医院
    Tianjin Medical University Cancer Institute & Hospital
    状态
    尚未招募
    登记库
    NCT07778940
  127. 研究 A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

    医院
    The Affiliated Hospital of Qingdao University
    状态
    尚未招募
    登记库
    NCT07485920
  128. 研究 A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer

    医院
    The First Affiliated Hospital of Fujian Medical University
    状态
    尚未招募
    登记库
    NCT07771764
  129. 研究 Comparing the Efficiency Between Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer: a Randomized, Controlled, Open-label, Single-center Phase III Clinical Trial

    主要研究者
    Peng Zhang · associate professor of medicine
    医院
    Shanghai Pulmonary Hospital
    状态
    尚未招募
    登记库
    NCT05496166
  130. 研究 Furmonertinib Combined With Local Therapy in Inoperable or Surgery-Refusing Early-Stage Non-Small Cell Lung Cancer:A Single-arm, Phase II Study

    主要研究者
    Xuefei Hu · Chief Physician
    医院
    Shanghai Pulmonary Hospital
    状态
    尚未招募
    登记库
    NCT07517640
  131. 研究 A Phase II Clinical Study of Adebelizumab Combined With Other Anti-tumor Treatments as a Perioperative Treatment for Resectable Non-small Cell Lung Cancer

    医院
    Shanghai Pulmonary Hospital
    状态
    尚未招募
    登记库
    NCT07704645
  132. 研究 An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on the Incidence of Pulmonary Infection and Survival in Lung Cancer Patients

    主要研究者
    Yalei Zhang · The First Affiliated Hospital of Guangzhou Medical University
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT07142057
  133. 研究 Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics

    主要研究者
    Jianxing He · Chief physician
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    尚未招募
    登记库
    NCT06893354
  134. 研究 Phase II, Open-label, Single-arm, Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Lorlatinib as Neoadjuvant Treatment in Surgically Resectable Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer (NEOLORA)

    主要研究者
    Yang Fan, MD · Professor of Thoracic Surgery
    医院
    Peking University People's Hospital
    状态
    尚未招募
    登记库
    NCT06682884
  135. 研究 The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial

    主要研究者
    Gang Hou · Professor
    医院
    China-Japan Friendship Hospital
    状态
    尚未招募
    登记库
    NCT06739421
  136. 研究 A Multi-cohort, Open-label Phase II Study to Evaluate the Efficacy and Safety of the Anti-EGFR/c-Met Bispecific Antibody MCLA-129 in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Gene Alterations and MET Amplification.

    医院
    The First Affiliated Hospital of Anhui Medical University
    状态
    尚未招募
    登记库
    NCT06885840

本页仅分享公开登记的研究信息,不推荐也不鼓励参加任何研究。参加完全自愿,且未经批准治疗的风险尚不明确;请直接联系医院了解入组条件与知情同意细节。

拥有国家临床重点专科记录的医院

显示医院记录 46 家拥有重点专科记录的医院

每一行都是在某疾病所归属专科中拥有国家临床重点专科记录的医院。这是对已发布名单的记录,既不构成推荐,也不是排名。

医院 城市 专科(按原样) 证据 来源
上海交通大学医学院附属瑞金医院Ruijin Hospital
三级 · 最高档
上海市 Shanghai 呼吸内科 B 级 https://www.rjh.com.cn/2018RJPortal/lcyxy2019/sy/jj/index.shtml
上海市第一人民医院Shanghai General Hospital
三级 · 最高档
上海市 Shanghai 呼吸科 B 级 https://www.firsthospital.cn/List/Depart/f0
上海市肺科医院Shanghai Pulmonary Hospital
三级 · 最高档
上海市 Shanghai 呼吸内科 · 胸外科 B 级 https://www.shsfkyy.com/gzb/list/b980f2cf4b134e5d85397ced965ce260/74344ed2746449a68d71c2b76c8cf423.html
上海市胸科医院(暨上海交通大学医学院附属胸科医院)Shanghai Chest Hospital
三级 · 最高档
上海市 Shanghai 胸外科专业 B 级 https://www.shxkyy.com/hz/list/190/1400.html
复旦大学附属中山医院Zhongshan Hospital
三级 · 最高档
上海市 Shanghai 呼吸内科 · 胸外科 B 级 https://www.zs-hospital.sh.cn/zhuanye/content/5140.html
中国医学科学院肿瘤医院Cancer Hospital of Chinese Academy of Medical Sciences 北京市 Beijing 胸外科 B 级 https://www.cicams.ac.cn/news/401.html
中日友好医院China-Japan Friendship Hospital 北京市 Beijing 呼吸与危重症医学科 · 胸外科 B 级 https://www.zryhyy.com.cn/zryh/c100020/202309/47e8245aa93343baac89762d4e80580f.shtml
北京医院Beijing Hospital
三级 · 最高档
北京市 Beijing 呼吸内科 · 胸外科 B 级 https://www.bjhmoh.cn/index.php?id=4&r=archives/about&t=1790009033
北京大学人民医院Peking University People's Hospital 北京市 Beijing 呼吸科 · 胸外科 B 级 https://www.pkuph.cn/news_details/26715.html
北京大学第一医院Peking University First Hospital 北京市 Beijing 胸外科 B 级 https://www.pkufh.com/Html/News/Articles/64494.html
北京大学第三医院Peking University Third Hospital 北京市 Beijing 呼吸与危重症医学科 B 级 https://www.puh3.net.cn/yygk/zdxk.htm
首都医科大学附属北京朝阳医院Beijing Chao-Yang Hospital, Capital Medical University 北京市 Beijing 呼吸与危重症医学科 B 级 https://www.bjcyh.com.cn/Html/News/Articles/21528.html
四川大学华西医院West China Hospital, Sichuan University
三级 · 最高档
成都市 Chengdu 呼吸内科 · 胸外科 A 级 https://wcums.scu.edu.cn/kxyan_jiu/gjlczdzk.htm
四川省医学科学院·四川省人民医院Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
三级 · 最高档
成都市 Chengdu 呼吸内科 B 级 https://www.samsph.com/introduce/
天津医科大学总医院Tianjin Medical University General Hospital
三级 · 最高档
天津市 Tianjin 呼吸内科 B 级 https://www.tjmugh.com.cn/system/2019/01/02/020008655.shtml
天津医科大学肿瘤医院Tianjin Medical University Cancer Institute & Hospital 天津市 Tianjin 胸外科 B 级 https://www.tjmuch.com/yygk/yyjj/index_yg.shtml
安徽医科大学第一附属医院The First Affiliated Hospital of Anhui Medical University 合肥市 Hefei 呼吸内科 B 级 https://www.ayfy.com/info/1184/27750.htm
山东大学齐鲁医院Qilu Hospital of Shandong University
三级 · 最高档
济南市 Jinan 呼吸内科 · 胸外科 A 级 http://wsjkw.shandong.gov.cn/wmfw/cxfw/202307/P020230717441794577839.xlsx
山东省千佛山医院Shandong Provincial Qianfoshan Hospital 济南市 Jinan 呼吸内科 · 胸外科 A 级 http://wsjkw.shandong.gov.cn/wmfw/cxfw/202307/P020230717441794577839.xlsx
https://file.byfy.cn/Resource/File/Upload/file/20251204/20251204085449_9136.pdf
中山大学肿瘤防治中心Sun Yat-sen University Cancer Center 广州市 Guangzhou 胸外科 B 级 https://sysucc.org.cn/department/introduction/41
中山大学附属第一医院The First Affiliated Hospital, Sun Yat-sen University 广州市 Guangzhou 呼吸内科 · 胸外科 B 级 https://gcp.fahsysu.org.cn/sites/1h.gcp.sysucloud1.sysu.edu.cn/files/2023-07/20230625%20中山大学附属第一医院宣传折页%20V5.0_0.pdf
南方医科大学南方医院Nanfang Hospital 广州市 Guangzhou 呼吸与危重症医学科 A 级 https://portal.smu.edu.cn/yzw/info/1023/11291.htm
广东省人民医院Guangdong Provincial People's Hospital 广州市 Guangzhou 胸外科 B 级 https://static.nfnews.com/content/202503/22/c11108498.html
广州医科大学附属第一医院First Affiliated Hospital of Guangzhou Medical University
三级 · 最高档
广州市 Guangzhou 呼吸内科 · 胸外科 B 级 https://www.gyfyyy.cn/cn/news/xwsd/index_88.html
江苏省人民医院(南京医科大学第一附属医院)Jiangsu Province Hospital
三级 · 最高档
南京市 Nanjing 呼吸与危重症医学科 B 级 https://www.jsph.org.cn/ksjj/ksjs/nk1/hxywzzyxk.htm
江苏省肿瘤医院Jiangsu Cancer Hospital
三级 · 最高档
南京市 Nanjing 胸外科 B 级 https://www.jszlyy.com.cn/home/news/content/id/476/pid/47579
河南省人民医院Henan Provincial People's Hospital 郑州市 Zhengzhou 呼吸与危重症医学科 B 级 https://www.hnsrmyy.net/jzzn/ksdh/nk/hxywzzyxk/ksjj.htm
河南省肿瘤医院Henan Cancer Hospital 郑州市 Zhengzhou 胸外科 B 级 https://www.anti-cancer.com.cn/Html/News/Articles/13202.html
郑州大学第一附属医院First Affiliated Hospital of Zhengzhou University 郑州市 Zhengzhou 呼吸内科 · 胸外科 B 级 C 级 https://www.zdyfy.cn/tsyl/gjjlczdzk
未发布
浙江大学医学院附属第一医院The First Affiliated Hospital, Zhejiang University School of Medicine
三级 · 最高档
杭州市 Hangzhou 呼吸内科 A 级 http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
浙江大学医学院附属第二医院The Second Affiliated Hospital Zhejiang University School of Medicine
三级 · 最高档
杭州市 Hangzhou 呼吸内科 A 级 http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
浙江大学医学院附属邵逸夫医院Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
三级 · 最高档
杭州市 Hangzhou 呼吸与危重症医学科 B 级 https://www.srrsh.com/sywhInfo/536
华中科技大学同济医学院附属协和医院Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 武汉市 Wuhan 呼吸与危重症医学科 · 胸外科 B 级 https://www.whuh.com/kxyj/xkjs/gjlczdzk.htm
https://www.whuh.com/kxyj/xkjs/gjlczdzk/2.htm
华中科技大学同济医学院附属同济医院Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
三级 · 最高档
武汉市 Wuhan 呼吸内科 · 胸外科 B 级 https://www.tjh.com.cn/contents/934/27291.html
武汉大学人民医院Renmin Hospital of Wuhan University 武汉市 Wuhan 胸外科 B 级 https://www.rmhospital.com/article/id/16939.html
中南大学湘雅三医院Third Xiangya Hospital
三级 · 最高档
长沙市 Changsha 呼吸与危重症医学科(培育项目) B 级 https://www.xy3yy.com/ksjj/184173.html
中南大学湘雅二医院Second Xiangya Hospital of Central South University 长沙市 Changsha 呼吸内科 · 胸外科 B 级 https://www.xyeyy.com/655/656/664/
中南大学湘雅医院Xiangya Hospital of Central South University
三级 · 最高档
长沙市 Changsha 呼吸内科 B 级 https://www.xiangya.com.cn/zdzk.html
中国医科大学附属盛京医院Shengjing Hospital
三级 · 最高档
沈阳市 Shenyang 呼吸科 · 胸外科 B 级 https://www.sj-hospital.cn/article/2816.html
https://www.sj-hospital.org/sjweekly/resfile/2024-01-26/16/sjzk-20240126-016.pdf
中国医科大学附属第一医院First Hospital of China Medical University
三级 · 最高档
沈阳市 Shenyang 呼吸与危重症医学科(呼吸系病) · 胸外科 A 级 B 级 https://www.cmu1h.com/features/specialty
https://wsjk.ln.gov.cn/wsjk/index/gsgg/D6FB5218203A456D9540155A2D928D84/index.shtml
辽宁省肿瘤医院Liaoning Cancer Hospital
三级 · 最高档
沈阳市 Shenyang 胸外科 B 级 https://www.lnchi.org.cn/ch/hospital/biref/index.html
重庆医科大学附属第一医院The First Affiliated Hospital of Chongqing Medical University 重庆市 Chongqing 呼吸内科 · 胸外科 B 级 https://www.hospital-cqmu.com/gzb/yygk/yyjj.htm
重庆医科大学附属第二医院The Second Affiliated Hospital of Chongqing Medical University 重庆市 Chongqing 呼吸内科 B 级 https://www.cqsahcqmu.cn/mobile/index.php?c=category&id=1013
西安交通大学第一附属医院The First Affiliated Hospital of Xi'an Jiaotong University
三级 · 最高档
西安市 Xi'an 呼吸内科 · 胸外科 B 级 https://news.xjtu.edu.cn/info/1033/17951.htm
http://www.dyyy.xjtu.edu.cn/info/41461/122341.htm
西安交通大学第二附属医院The Second Affiliated Hospital of Xi'an Jiaotong University
三级 · 最高档
西安市 Xi'an 呼吸内科 B 级 https://news.xjtu.edu.cn/info/1219/169067.htm
陕西省人民医院Shaanxi Provincial People's Hospital 西安市 Xi'an 呼吸内科 B 级 https://www.spph-sx.com/zlfw1/zdzk.htm

46 家拥有匹配的国家临床重点专科记录的医院。

以中文写出的数值按来源原样引用。

患者报告的情况

仅为汇总数据:一项全国性结果,附其来源与所指年份。这不是患者证言,也不是关于某一个人的陈述。

  • 据 National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号)(2023)报道:National inpatient satisfaction / outpatient satisfaction — 95.42 / 93.95 score, 0-100。

    National aggregate across the 2,168 tertiary public hospitals that took part in the national performance monitoring (all conditions combined; not disease-specific, not hospital-specific).

    来源:National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号) — https://www.gov.cn/zhengce/zhengceku/202503/content_7016208.htm — 2023 — A 级

报告的副作用

某临床试验中一种副作用的比率,附其来源与获取日期。它是单一试验的比率,而非全国性比率。

  • 据 ClinicalTrials.gov results - NCT01310036(2026-10-05)报道:Pneumonia (serious adverse event) — 10 / 207 (about 4.8%) participants。

    Single trial: erlotinib 150 mg daily, safety population n=207, systematic assessment, MedDRA 19.1, 5% frequency threshold. It is a single-trial rate for one study population, not a national rate.

    来源:ClinicalTrials.gov results - NCT01310036 — https://clinicaltrials.gov/api/v2/studies/NCT01310036 — 2026-10-05 — B 级

全部疗法与获取主题

关于该疾病的问题

我们不能提供医疗建议,但可以回答关于本页以及在中国安排就医的问题。

咨询这个病种

ICD 编码

显示编码表 7 个 ICD 编码
版本 编码 该版本中的名称
ICD-10-WHO C34 Malignant neoplasm of bronchus and lung
ICD-10-WHO C34.0 Main bronchus
ICD-10-WHO C34.1 Upper lobe, bronchus or lung
ICD-10-WHO C34.2 Middle lobe, bronchus or lung
ICD-10-WHO C34.3 Lower lobe, bronchus or lung
ICD-10-WHO C34.8 Overlapping lesion of bronchus and lung
ICD-10-WHO C34.9 Bronchus or lung, unspecified

各行为该疾病的 WHO ICD-10 条目,按原样引用。

来源与证据

来源 URL
https://wjw.fujian.gov.cn/xxgk/fgwj/zxwj/201904/P020190412506737868905.xlsx
来源协议
https
来源类型
省级卫生健康委员会
证据等级
A ——由卫生健康委员会、国家级研究机构或大学所述
获取日期
2026-09-24